TargetMol Chemicals Inc.

Firmenname:TargetMol Chemicals Inc.

Telefon:-

E-Mail:marketing@targetmol.com

Nationalität:China

Produkte insgesamt:19711

40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144

Produktkatalog

IRE1α kinase-IN-8	1338933-29-1
Antifungal agent 59	2422019-96-1
VMAT2-IN-2 tosylate	2608770-12-1	C27H36F3NO6S
Bivamelagon hydrochloride	2641595-55-1	C35H54Cl2N4O4
KAT modulator-1	1314006-43-3	C20H36O2
DRI-C21041	2101765-78-8	C30H21N3O7S
ATR-IN-24	2370889-43-1	C23H26N6O2
STAT6-IN-3	371919-80-1	C32H35IN3O7P
SOS1-IN-16	2930763-85-0
BET-IN-15	2408994-22-7	C21H18F2N4O3S
BBDDL2059	2691174-27-1
Tegeprotafib	2407610-46-0	C13H11FN2O5S
S-Gem	2169925-98-6	C13H15F2N3O6S2
Lp-PLA2-IN-16	1865780-73-9	C22H17F5N4O3
URAT1&XO inhibitor 1	2669726-78-5
IRE1α kinase-IN-9	1338933-30-4
IPG7236	2756350-91-9	C23H31N3O3S
PIKfyve-IN-2	2245319-25-7
Lp-PLA2-IN-15	1865796-11-7	C22H17F5N4O3
Bivamelagon	2641595-54-0	C35H53ClN4O4
SHP2-IN-14	2673400-91-2
P2X3 antagonist 38	2545974-71-6
DRI-C25441	2101765-83-5	C31H21N3O6
Lp-PLA2-IN-13	2756855-62-4
RET-IN-23	2479961-46-9	C28H28FN11
SOS1/KRAS-IN-1	2836330-34-6
Bromodomain inhibitor-12 (edisylate)	2010124-27-1
Bromodomain inhibitor-12	2010124-06-6
URAT1&XO inhibitor 2	1239488-96-0	C14H12BrNO3
CXCR4-IN-1	2304750-48-7
TLR7/8 agonist 8	2649170-16-9	C24H30N6O
FKBP51F67V-selective antagonist Ligand2	1680228-76-5
TLR8 agonist 6	2616605-55-9	C19H29N7O2
DGKζ-IN-1	2660218-70-0	C27H25F3N6O2S
PI3Kγ inhibitor 7	2575863-25-9
Lp-PLA2-IN-14	2756855-66-8
Protein kinase inhibitor 5	2278204-94-5	C29H31F2N7O
JAK-IN-28	2445500-22-9
PCSK9-IN-17	2455424-72-1
HPK1 antagonist-1	2628489-56-3	C28H29FN6O2
SUCNR1-IN-1	2711753-52-3
Mosnodenvir	2890688-86-3
TLR7/8 agonist 9	2649170-17-0	C20H26N6O
THRβ receptor agonist-1	2403721-00-4
ROCK-IN-6	2489328-74-5	C19H19N5O8S
ALK/EGFR-IN-1	2730430-08-5
Antileishmanial agent-16	2934738-41-5
Tau protein aggregation-IN-1	916179-45-8	C17H11BrN2O2
PAD4-IN-2	2642327-52-2
MAT2A-IN-12	631897-75-1	C20H17NO3
PHD2-IN-1	2768219-28-7
Antileishmanial agent-15	2934738-38-0
Antitumor agent-101	2848632-52-8
Antileishmanial agent-17	2934738-40-4
SSI-4	1875084-68-6	C19H21ClN4O3
RIP1 kinase inhibitor 6	2428401-62-9
DSO-5a	2195411-63-1
UPCDC30766	2152623-68-0
FGFR-IN-11	2658488-68-5
Antiproliferative agent-30	2713553-88-7
RIP1 kinase inhibitor 4	2919836-00-1
BDM91514	2892824-90-5
Antitubercular agent-39	1357796-08-7
FD2056	2685870-87-3
Antiproliferative agent-34	2910858-34-1
ETAP	2575731-47-2
Antibacterial agent 141	2930013-56-0
JAK-IN-30	2891469-99-9
PB131	2924425-63-6
MDM2/XIAP-IN-2	2761969-85-9	C29H32N2O4S
Tubulin polymerization-IN-42	2640220-51-3
MmpL3-IN-2	2944458-65-3
MEK-IN-6 hydrate	2845153-35-5
TNF-α-IN-10	2247720-56-3
SARS-CoV-2-IN-57	1265624-68-7
IRAK4-IN-28	2952532-92-0
Mcl-1 inhibitor 13	2445466-06-6
MEK-IN-6	2845151-86-0
BChE-IN-17	2425632-57-9
AMPA receptor modulator-4	2917551-59-6	C11H12ClFN2O2S
A1/A3 AR antagonist 3	2665804-57-7	C22H19N5O3
ALK2-IN-5	2414149-20-3	C24H32N8O2
HIV-1 inhibitor-56	2952530-45-7
Antiproliferative agent-32	2925814-05-5
AMPK activator 11	2948304-00-3
PROTAC α-synuclein degrader 5	2781922-42-5	C39H41N7O10
Anticancer agent 147	2241283-11-2
SLMP53-2	1826116-38-4	C26H22N2O2
RIP1 kinase inhibitor 7	2428401-23-2
Lp-PLA2-IN-12	2637485-14-2
Enpp-1-IN-17	2289736-54-3	C18H24N4O2
TRK-IN-23	2924344-29-4
Z1078601926	1493256-85-1	C14H19FN2O
HDAC ligand-1	34840-28-3	C7H8N2O
SORT-PGRN interaction inhibitor 3	2691846-87-2	C15H19Cl2NO3
K-80001	242800-40-4
CDK7-IN-22	2173190-60-6	C22H25F3N6
PCSK9-IN-16	2455424-51-6	C16H20N6O2S3
RIP1 kinase inhibitor 5	2428422-17-5	C13H17F2NO2